Suppr超能文献

外源性肝素衍生物治疗对高胆固醇饮食喂养大鼠主动脉紊乱和脂蛋白氧化的动脉粥样硬化保护作用

Atheroprotective effect of exogenous heparin-derivative treatment on the aortic disturbances and lipoprotein oxidation in hypercholesterolemic diet fed rats.

作者信息

Deepa P R, Varalakshmi P

机构信息

Department of Medical Biochemistry, Dr. ALM Post Graduate Institute of Basic Medical Sciences, University of Madras, Taramani campus, Chennai 600 113, India.

出版信息

Clin Chim Acta. 2005 May;355(1-2):119-30. doi: 10.1016/j.cccn.2004.12.007.

Abstract

BACKGROUND

The present work explores the myriad of biochemical and cellular changes that are featured in the early stages of atherosclerosis; if unchecked these changes lead to the complicated atherosclerotic plaque formation. The influence of a low-molecular-weight heparin derivative on the aortic aberrations and lipoprotein oxidation has been assessed in an experimental model of hypercholesterolemic atherogenesis.

METHODS

Two groups of male Wistar rats (140+/-10 g) were fed a hypercholesterolemic atherogenic diet (rat chow supplemented with 4% cholesterol, 1% cholic acid and 0.5% thiouracil; CCT diet) for 2 weeks; one of these groups received LMWH (Certoparin) treatment of 300 microg/day/rat, s.c. for 7 days. An untreated control and a LMWH drug control group were also included.

RESULTS

Abnormal increase in the aortic lipids -glycosaminoglycans levels (p<0.001) in CCT-diet fed group was circumvented by the exogenous glycosaminoglycan (LMWH) treatment (p<0.001). The escalation of oxidative stress (markers-lipid peroxidation and thiol levels, superoxide dismutase and catalase activities) in the atherogenic aorta was minimised by LMWH treatment. Further, an increased susceptibility of the apo B-containing lipoproteins (LDL+VLDL) to oxidation in vitro, induced by copper ions and Fenton's reagent, was observed in the untreated CCT diet fed group. This paper reports the favorable modulation of these oxidative changes by LMWH administration. Vascular protection by LMWH is further substantiated by the normal aortic histologic findings as against the appearance of foam cells in the untreated atherogenic group.

CONCLUSION

The exogenous heparin-derivative (LMWH) treatment attempted in this experimental model of hypercholesterolemic atherogenesis affords substantial protection against abnormal levels of aortic lipids and glycosaminoglycans, aortic oxidative stress and also stunts the lipoprotein peroxidative process, thereby proving its multi-faceted anti-atherogenic effects.

摘要

背景

本研究探讨动脉粥样硬化早期阶段出现的众多生化和细胞变化;如果不加以控制,这些变化会导致复杂的动脉粥样硬化斑块形成。在高胆固醇血症动脉粥样硬化形成的实验模型中,评估了一种低分子量肝素衍生物对主动脉异常和脂蛋白氧化的影响。

方法

两组雄性Wistar大鼠(140±10克)喂食高胆固醇致动脉粥样硬化饮食(添加4%胆固醇、1%胆酸和0.5%硫脲的大鼠饲料;CCT饮食)2周;其中一组接受低分子量肝素(Certoparin)治疗,剂量为300微克/天/大鼠,皮下注射7天。还包括一个未治疗的对照组和一个低分子量肝素药物对照组。

结果

喂食CCT饮食组主动脉脂质-糖胺聚糖水平异常升高(p<0.001),外源性糖胺聚糖(低分子量肝素)治疗可避免这种情况(p<0.001)。低分子量肝素治疗可将动脉粥样硬化主动脉中氧化应激(标志物-脂质过氧化和硫醇水平、超氧化物歧化酶和过氧化氢酶活性)的升高降至最低。此外,在未治疗的喂食CCT饮食组中,观察到含载脂蛋白B的脂蛋白(LDL+VLDL)在体外对铜离子和芬顿试剂诱导氧化的敏感性增加。本文报道了低分子量肝素给药对这些氧化变化的有利调节作用。与未治疗的动脉粥样硬化组中出现泡沫细胞的情况相比,低分子量肝素对血管的保护作用在主动脉组织学正常结果中得到进一步证实。

结论

在这个高胆固醇血症动脉粥样硬化形成的实验模型中尝试的外源性肝素衍生物(低分子量肝素)治疗,对主动脉脂质和糖胺聚糖的异常水平、主动脉氧化应激提供了实质性保护,还抑制了脂蛋白过氧化过程,从而证明了其多方面的抗动脉粥样硬化作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验